Sarah Cannon Res Inst

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Genentech, Inc.1 trial
• Hoffmann-La Roche1 trial

Running trials

• Active, not recruiting

  A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

  NCT03148418· Phase 3· Hoffmann-La Roche· Source

Closed trials

• Completed

  A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

  NCT03289962· Phase 1· Genentech, Inc.· Source